We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca’s Cancer Drug Zictifa Wins Advisory Committee Support
AstraZeneca’s Cancer Drug Zictifa Wins Advisory Committee Support
December 3, 2010
An FDA advisory committee has given its support to AstraZeneca’s thyroid cancer treatment Zictifa, saying agency concerns about the drug’s safety were not enough to justify limiting its indication.